Côte d'Ivoire vs Lao People's Democratic Republic: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Côte d'Ivoire
0.6%
in 2024
Lao People's Democratic Republic
0.6%
in 2024
Côte d'Ivoire rank
60th
Lao People's Democratic Republic rank
60th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Côte d'Ivoire
- Lao People's Democratic Republic
How they compare
Côte d'Ivoire currently reports 0.6% against 0.6% in Lao People's Democratic Republic, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Lao People's Democratic Republic ahead.
Côte d'Ivoire ranks 60th and Lao People's Democratic Republic ranks 60th of 246 countries.
Lao People's Democratic Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Lao People's Democratic Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.2% | 1.3% | 0.1% | Lao People's Democratic Republic |
| 2020s | 0.7% | 0.7% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Côte d'Ivoire or Lao People's Democratic Republic?
- Côte d'Ivoire, at 0.6% against 0.6% in Lao People's Democratic Republic as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Côte d'Ivoire and Lao People's Democratic Republic?
- 0.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Lao People's Democratic Republic?
- 10 years are reported by both, from 2015 to 2024.
- How do Côte d'Ivoire and Lao People's Democratic Republic rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Côte d'Ivoire ranks 60th and Lao People's Democratic Republic ranks 60th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.